🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
162.64
+0.54 (0.33%)
At close: Nov 20, 2026, 4:00 PM EST
162.83
+0.19 (0.12%)
After-hours: Nov 20, 2026, 7:30 PM EST

Nutex Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
164.7170.7952.1-45.79-424.78132.59
Depreciation & Amortization
21.6220.5318.9717.5913.137.66
Other Amortization
0.210.91.041.211.950.05
Asset Writedown & Restructuring Costs
--7.5430.22398.14-
Stock-Based Compensation
3.7511716.562.840.19-
Other Operating Activities
11.84126.6431.19-3.29-2.3430.37
Change in Accounts Receivable
33.97-89.32-173.41-4.5858.08-6.62
Change in Inventory
-1.99-0.020.540.14-0.72-1.09
Change in Accounts Payable
-3.9637.85-10.72-2.259.696.27
Change in Income Taxes
16.06-25.6726.53---
Change in Other Net Operating Assets
12.23-10.652.825.16-2.734.2
Operating Cash Flow
258.45248.1323.151.2650.61173.43
Operating Cash Flow Growth
45.37%971.67%1741.93%-97.52%-70.82%100.10%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-12.67-6.84-2.3-9.5-14.63-36.93
Cash Acquisitions
----0.712.72-
Divestitures
---0.36-1.04-2.42-0.05
Other Investing Activities
-1.351.6-2.94---
Investing Cash Flow
-14.02-5.24-5.61-11.24-4.34-36.98

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-5.042.262.342.62-
Long-Term Debt Issued
--7.0221.860.8219.61
Total Debt Issued
0.665.049.2824.23.4419.61
Short-Term Debt Repaid
--7.86-2.08-1.59-0.07-0.86
Long-Term Debt Repaid
--16.63-14.6-19.96-8.96-21.97
Total Debt Repaid
-18.81-24.48-16.68-21.56-9.03-22.84
Net Debt Issued (Repaid)
-18.15-19.44-7.42.65-5.59-3.22
Issuance of Common Stock
2.430.7714.930.39.2821.75
Repurchase of Common Stock
-55.69-5----
Common Dividends Paid
-----34.35-111.69
Other Financing Activities
-85.81-74.28-6.44-5.22-17.47-32.69
Financing Cash Flow
-157.22-97.951.09-2.27-48.13-125.85

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
87.22144.9318.64-12.25-1.8610.6

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
245.78241.2920.85-8.2435.97136.51
Free Cash Flow Growth
41.02%1057.31%---73.65%435.68%
Free Cash Flow Margin
30.86%27.57%4.34%-3.33%16.41%41.17%
Free Cash Flow Per Share
34.9335.713.80-1.878.5034.54
Levered Free Cash Flow
157.44152.8113.180.4753.481.1
Unlevered Free Cash Flow
169.23165.824.69.4659.2684.92

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
3.022.513.471.644.624.1
Cash Income Tax Paid
47.2572.820.80.858.230.34
Change in Working Capital
56.32-87.74-104.24-1.5364.322.75
SEC Filings: 10-K · 10-Q